North American Nerve Repair & Regeneration Market by Type (Neurostimulation, Nerve Conduits, Nerve Protectors, Nerve Wraps, Nerve Connectors), by Procedure (Direct Nerve Repair, Nerve Grafting, Neuromodulation Surgery, Stem Cell Therapy) - Forecast to 2019
The nerve repair and regeneration market in North America is projected to grow at a strong rate—a CAGR of 11.4 %. The U.S. held the maximum market share, followed by Canada and Mexico. By product, the market is divided into nerve repair by biomaterials and nerve repair by neurostimulation (which holds the larger market share).
There are numerous opportunities in the market for players, including the rising number of surgeries and increasing healthcare expenditure. Key restraints for this market include a lack of availability of neurosurgeons and a lack of awareness.
The report shares a competitive view of the various companies operating in the market, in terms of the geographies they operate in, revenue generated, and their market shares. Key market players listed in this report are Integra LifeSciences Corporation, Stryker, and Medtronic, Inc., among others.
There are numerous opportunities in the market for players, including the rising number of surgeries and increasing healthcare expenditure. Key restraints for this market include a lack of availability of neurosurgeons and a lack of awareness.
The report shares a competitive view of the various companies operating in the market, in terms of the geographies they operate in, revenue generated, and their market shares. Key market players listed in this report are Integra LifeSciences Corporation, Stryker, and Medtronic, Inc., among others.
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET SEGMENTATION & COVERAGE
1.3 STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 INTEGRATED ECOSYSTEM OF NERVE REPAIR AND REGENERATION MARKET
2.1.1 TOP-DOWN APPROACH
2.1.2 BOTTOM-UP APPROACH
2.1.3 MACROINDICATOR-BASED APPROACH
2.2 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 MARKET OVERVIEW
4.1 INTRODUCTION
4.2 NERVE REPAIR AND REGENERATION MARKET: COMPARISON WITH PARENT MARKET (NEUROLOGY DEVICES MARKET)
4.3 MARKET DRIVERS AND INHIBITORS
5 NERVE REPAIR AND REGENERATION MARKET, BY PRODUCT
5.1 INTRODUCTION
5.2 NORTH AMERICAN NERVE REPAIR AND REGENERATION MARKET, BY PRODUCT: COMPARISON WITH PARENT MARKET
5.3 NORTH AMERICAN NERVE REPAIR BY BIOMATERIALS MARKET, BY COUNTRY
5.4 NORTH AMERICA: NERVE REPAIR BY NEUROSTIMULATION MARKET, BY COUNTRY
6 NERVE REPAIR AND REGENERATION MARKET, BY COUNTRY
6.1 INTRODUCTION
6.2 U.S. NERVE REPAIR AND REGENERATION MARKET
6.2.1 U.S.: NERVE REPAIR AND REGENERATION MARKET, BY TYPE
6.3 CANADA: NERVE REPAIR AND REGENERATION MARKET
6.3.1 CANADA: NERVE REPAIR AND REGENERATION MARKET, BY PRODUCT
6.4 MEXICO: NERVE REPAIR AND REGENERATION MARKET
6.4.1 MEXICO: NERVE REPAIR AND REGENERATION MARKET, BY PRODUCT
7 NERVE REPAIR AND REGENERATION MARKET: COMPETITIVE LANDSCAPE
7.1 NERVE REPAIR AND REGENERATION MARKET: COMPANY SHARE ANALYSIS
7.2 MERGERS & ACQUISITIONS
7.3 EXPANSIONS AND COLLABORATIONS
8 NERVE REPAIR AND REGENERATION MARKET: COMPANY PROFILES
8.1 INTEGRA LIFESCIENCES CORPORATION
8.1.1 BUSINESS OVERVIEW
8.1.2 KEY FINANCIALS
8.1.3 PRODUCT AND SERVICE OFFERINGS
8.1.4 RELATED DEVELOPMENTS
8.2 AXOGEN, INC.
8.2.1 OVERVIEW
8.2.2 KEY OPERATIONS DATA
8.2.3 PRODUCT AND SERVICE OFFERINGS
8.2.4 RELATED DEVELOPMENTS
8.3 POLYGANICS
8.3.1 OVERVIEW
8.3.2 KEY OPERATIONS DATA
8.3.3 PRODUCT AND SERVICE OFFERINGS
8.3.4 RELATED DEVELOPMENTS
8.4 STRYKER
8.4.1 OVERVIEW
8.4.2 KEY FINANCIALS
8.4.3 PRODUCT AND SERVICE OFFERINGS
8.4.4 RELATED DEVELOPMENTS
8.5 ST. JUDE MEDICAL
8.5.1 OVERVIEW
8.5.2 KEY FINANCIALS
8.5.3 PRODUCT AND SERVICE OFFERINGS
8.5.4 RELATED DEVELOPMENTS
8.6 MEDTRONIC, PLC.
8.6.1 OVERVIEW
8.6.2 KEY FINANCIALS
8.6.3 PRODUCT AND SERVICE OFFERINGS
8.6.4 RELATED DEVELOPMENTS
9 APPENDIX
9.1 CUSTOMIZATION OPTIONS
9.1.1 TECHNICAL ANALYSIS
9.1.2 LOW-COST SOURCING LOCATIONS
9.1.3 REGULATORY FRAMEWORK
9.1.4 IMPACT ANALYSIS
9.1.5 HISTORICAL DATA AND TRENDS
9.2 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
9.2.1 RT SNAPSHOTS
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET SEGMENTATION & COVERAGE
1.3 STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 INTEGRATED ECOSYSTEM OF NERVE REPAIR AND REGENERATION MARKET
2.1.1 TOP-DOWN APPROACH
2.1.2 BOTTOM-UP APPROACH
2.1.3 MACROINDICATOR-BASED APPROACH
2.2 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 MARKET OVERVIEW
4.1 INTRODUCTION
4.2 NERVE REPAIR AND REGENERATION MARKET: COMPARISON WITH PARENT MARKET (NEUROLOGY DEVICES MARKET)
4.3 MARKET DRIVERS AND INHIBITORS
5 NERVE REPAIR AND REGENERATION MARKET, BY PRODUCT
5.1 INTRODUCTION
5.2 NORTH AMERICAN NERVE REPAIR AND REGENERATION MARKET, BY PRODUCT: COMPARISON WITH PARENT MARKET
5.3 NORTH AMERICAN NERVE REPAIR BY BIOMATERIALS MARKET, BY COUNTRY
5.4 NORTH AMERICA: NERVE REPAIR BY NEUROSTIMULATION MARKET, BY COUNTRY
6 NERVE REPAIR AND REGENERATION MARKET, BY COUNTRY
6.1 INTRODUCTION
6.2 U.S. NERVE REPAIR AND REGENERATION MARKET
6.2.1 U.S.: NERVE REPAIR AND REGENERATION MARKET, BY TYPE
6.3 CANADA: NERVE REPAIR AND REGENERATION MARKET
6.3.1 CANADA: NERVE REPAIR AND REGENERATION MARKET, BY PRODUCT
6.4 MEXICO: NERVE REPAIR AND REGENERATION MARKET
6.4.1 MEXICO: NERVE REPAIR AND REGENERATION MARKET, BY PRODUCT
7 NERVE REPAIR AND REGENERATION MARKET: COMPETITIVE LANDSCAPE
7.1 NERVE REPAIR AND REGENERATION MARKET: COMPANY SHARE ANALYSIS
7.2 MERGERS & ACQUISITIONS
7.3 EXPANSIONS AND COLLABORATIONS
8 NERVE REPAIR AND REGENERATION MARKET: COMPANY PROFILES
8.1 INTEGRA LIFESCIENCES CORPORATION
8.1.1 BUSINESS OVERVIEW
8.1.2 KEY FINANCIALS
8.1.3 PRODUCT AND SERVICE OFFERINGS
8.1.4 RELATED DEVELOPMENTS
8.2 AXOGEN, INC.
8.2.1 OVERVIEW
8.2.2 KEY OPERATIONS DATA
8.2.3 PRODUCT AND SERVICE OFFERINGS
8.2.4 RELATED DEVELOPMENTS
8.3 POLYGANICS
8.3.1 OVERVIEW
8.3.2 KEY OPERATIONS DATA
8.3.3 PRODUCT AND SERVICE OFFERINGS
8.3.4 RELATED DEVELOPMENTS
8.4 STRYKER
8.4.1 OVERVIEW
8.4.2 KEY FINANCIALS
8.4.3 PRODUCT AND SERVICE OFFERINGS
8.4.4 RELATED DEVELOPMENTS
8.5 ST. JUDE MEDICAL
8.5.1 OVERVIEW
8.5.2 KEY FINANCIALS
8.5.3 PRODUCT AND SERVICE OFFERINGS
8.5.4 RELATED DEVELOPMENTS
8.6 MEDTRONIC, PLC.
8.6.1 OVERVIEW
8.6.2 KEY FINANCIALS
8.6.3 PRODUCT AND SERVICE OFFERINGS
8.6.4 RELATED DEVELOPMENTS
9 APPENDIX
9.1 CUSTOMIZATION OPTIONS
9.1.1 TECHNICAL ANALYSIS
9.1.2 LOW-COST SOURCING LOCATIONS
9.1.3 REGULATORY FRAMEWORK
9.1.4 IMPACT ANALYSIS
9.1.5 HISTORICAL DATA AND TRENDS
9.2 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
9.2.1 RT SNAPSHOTS
LIST OF TABLES
Table 1 GLOBAL NERVE REGENERATION PEER MARKET SIZE, 2014 (USD MN)
Table 2 NORTH AMERICA NERVE REPAIR AND REGENERATION MARKET: MACRO INDICATORS, BY COUNTRY, 2014 (HEALTHCARE EXPENDITURE) (USD MN)
Table 3 NERVE REPAIR AND REGENERATION MARKET: COMPARISON WITH PARENT MARKET (NEUROLOGY DEVICES MARKET), 2013–2019 (USD MN)
Table 4 NORTH AMERICAN NERVE REPAIR AND REGENERATION MARKET: DRIVERS AND INHIBITORS
Table 5 NORTH AMERICA: NERVE REPAIR AND REGENERATION MARKET, BY PRODUCT, 2013–2019 (USD MN)
Table 6 NORTH AMERICA NERVE REPAIR AND REGENERATION MARKET, BY COUNTRY, 2013–2019 (USD MN)
Table 7 NORTH AMERICA NERVE REPAIR AND REGENERATION MARKET, BY PRODUCT, 2013–2019 (USD MN)
Table 8 NORTH AMERICA NERVE REPAIR AND REGENERATION MARKET, BY PRODUCT: COMPARISON WITH PARENT MARKET, 2013–2019 (USD MN)
Table 9 NORTH AMERICA: NERVE REPAIR BY BIOMATERIALS MARKET, BY COUNTRY, 2013–2019 (USD MN)
Table 10 NORTH AMERICA: NERVE REPAIR BY NEUROSTIMULATION MARKET, BY COUNTRY, 2013–2019 (USD MN)
Table 11 NORTH AMERICA: NERVE REPAIR AND REGENERATION MARKET, BY COUNTRY, 2013–2019 (USD MN)
Table 12 U.S.: NERVE REPAIR AND REGENERATION MARKET, BY PRODUCT, 2013–2019 (USD MN)
Table 13 CANADA: NERVE REPAIR AND REGENERATION MARKET, BY PRODUCT, 2013–2019 (USD MN)
Table 14 MEXICO: NERVE REPAIR AND REGENERATION MARKET, BY PRODUCT, 2013–2019 (USD MN)
Table 15 NERVE REPAIR AND REGENERATION MARKET: COMPANY SHARE ANALYSIS, 2014 (%)
Table 16 MERGERS & ACQUISITIONS
Table 17 EXPANSIONS AND COLLABORATIONS
Table 18 PRODUCT LAUNCHES
Table 19 INTEGRA LIFESCIENCES CORP.: KEY FINANCIALS, 2008–2013 (USD MN)
Table 20 AXOGEN, INC.: KEY OPERATIONS DATA, 2009–2013 (USD MN)
Table 21 STRYKER: KEY FINANCIALS, 2009–2013 (USD MN)
Table 22 ST. JUDE MEDICAL: KEY FINANCIALS, 2009–2013 (USD MN)
Table 23 MEDTRONIC: KEY FINANCIALS, 2009–2013 (USD MN)
Table 1 GLOBAL NERVE REGENERATION PEER MARKET SIZE, 2014 (USD MN)
Table 2 NORTH AMERICA NERVE REPAIR AND REGENERATION MARKET: MACRO INDICATORS, BY COUNTRY, 2014 (HEALTHCARE EXPENDITURE) (USD MN)
Table 3 NERVE REPAIR AND REGENERATION MARKET: COMPARISON WITH PARENT MARKET (NEUROLOGY DEVICES MARKET), 2013–2019 (USD MN)
Table 4 NORTH AMERICAN NERVE REPAIR AND REGENERATION MARKET: DRIVERS AND INHIBITORS
Table 5 NORTH AMERICA: NERVE REPAIR AND REGENERATION MARKET, BY PRODUCT, 2013–2019 (USD MN)
Table 6 NORTH AMERICA NERVE REPAIR AND REGENERATION MARKET, BY COUNTRY, 2013–2019 (USD MN)
Table 7 NORTH AMERICA NERVE REPAIR AND REGENERATION MARKET, BY PRODUCT, 2013–2019 (USD MN)
Table 8 NORTH AMERICA NERVE REPAIR AND REGENERATION MARKET, BY PRODUCT: COMPARISON WITH PARENT MARKET, 2013–2019 (USD MN)
Table 9 NORTH AMERICA: NERVE REPAIR BY BIOMATERIALS MARKET, BY COUNTRY, 2013–2019 (USD MN)
Table 10 NORTH AMERICA: NERVE REPAIR BY NEUROSTIMULATION MARKET, BY COUNTRY, 2013–2019 (USD MN)
Table 11 NORTH AMERICA: NERVE REPAIR AND REGENERATION MARKET, BY COUNTRY, 2013–2019 (USD MN)
Table 12 U.S.: NERVE REPAIR AND REGENERATION MARKET, BY PRODUCT, 2013–2019 (USD MN)
Table 13 CANADA: NERVE REPAIR AND REGENERATION MARKET, BY PRODUCT, 2013–2019 (USD MN)
Table 14 MEXICO: NERVE REPAIR AND REGENERATION MARKET, BY PRODUCT, 2013–2019 (USD MN)
Table 15 NERVE REPAIR AND REGENERATION MARKET: COMPANY SHARE ANALYSIS, 2014 (%)
Table 16 MERGERS & ACQUISITIONS
Table 17 EXPANSIONS AND COLLABORATIONS
Table 18 PRODUCT LAUNCHES
Table 19 INTEGRA LIFESCIENCES CORP.: KEY FINANCIALS, 2008–2013 (USD MN)
Table 20 AXOGEN, INC.: KEY OPERATIONS DATA, 2009–2013 (USD MN)
Table 21 STRYKER: KEY FINANCIALS, 2009–2013 (USD MN)
Table 22 ST. JUDE MEDICAL: KEY FINANCIALS, 2009–2013 (USD MN)
Table 23 MEDTRONIC: KEY FINANCIALS, 2009–2013 (USD MN)
LIST OF FIGURES
Figure 1 NORTH AMERICA NERVE REPAIR AND REGENERATION MARKET: SEGMENTATION & COVERAGE
Figure 2 NERVE REPAIR AND REGENERATION MARKET: INTEGRATED ECOSYSTEM
Figure 3 TOP-DOWN APPROACH
Figure 4 BOTTOM-UP APPROACH
Figure 5 MACROINDICATOR-BASED APPROACH
Figure 6 NORTH AMERICA NERVE REGENERATION AND REPAIR MARKET SNAPSHOT
Figure 7 NERVE REPAIR AND REGENERATION: COMPARISON WITH PARENT MARKET
Figure 8 NORTH AMERICA: NERVE REPAIR AND REGENERATION MARKET BREAKDOWN
Figure 9 NORTH AMERICA NERVE REPAIR AND REGENERATION MARKET, BY TYPE, 2014–2019 (USD MN)
Figure 10 NORTH AMERICAN NERVE REPAIR AND REGENERATION MARKET, BY PRODUCT: COMPARISON WITH NEUROLOGY DEVICES MARKET, 2013–2019 (USD MN)
Figure 11 NORTH AMERICAN NERVE REPAIR BY BIOMATERIALS MARKET, BY COUNTRY, 2013–2019 (USD MN)
Figure 12 NORTH AMERICA NERVE REPAIR BY NEUROSTIMULATION, BY COUNTRY, 2013–2019 (USD MN)
Figure 13 NORTH AMERICAN NERVE REPAIR AND REGENERATION MARKET: GROWTH ANALYSIS, BY COUNTRY, 2013–2019 (USD MN)
Figure 14 U.S. NERVE REPAIR AND REGENERATION MARKET OVERVIEW, 2014 & 2019 (%)
Figure 15 U.S. NERVE REPAIR AND REGENERATION MARKET, BY TYPE, 2013–2019 (USD MN)
Figure 16 U.S.: NERVE REPAIR AND REGENERATION MARKET, BY TYPE, 2014 VS. 2019 (%)
Figure 17 CANADA: NERVE REPAIR AND REGENERATION MARKET OVERVIEW, 2014 & 2019 (%)
Figure 18 CANADA: NERVE REPAIR AND REGENERATION MARKET, BY PRODUCT, 2013–2019 (USD MN)
Figure 19 CANADA: NERVE REPAIR AND REGENERATION MARKET, BY PRODUCT, 2014 VS
Figure 20 MEXICO NERVE REPAIR AND REGENERATION MARKET OVERVIEW, 2014 & 2019 (%)
Figure 21 MEXICO NERVE REPAIR AND REGENERATION MARKET, BY PRODUCT, 2013–2019 (USD MN)
Figure 22 MEXICO: NERVE REPAIR AND REGENERATION MARKET, BY PRODUCT, 2014 VS 2019
Figure 23 NERVE REPAIR AND REGENERATION MARKET: COMPANY SHARE ANALYSIS, 2013(%)
Figure 24 INTEGRA LIFESCIENCES HOLDINGS CORPORATION: REVENUE MIX, 2013 (%)
Figure 25 CONTRIBUTION OF NEUROSURGERY SEGMENT TOWARDS COMPANY REVENUES, 2008-2013 (USD MN)
Figure 26 STRYKER: GEOGRAPHIC REVENUE MIX, 2013 (%)
Figure 27 ST. JUDE MEDICAL, REVENUE MIX, 2013 (%)
Figure 28 MEDTRONIC, INC.: REVENUE MIX 2013 (%)
Figure 1 NORTH AMERICA NERVE REPAIR AND REGENERATION MARKET: SEGMENTATION & COVERAGE
Figure 2 NERVE REPAIR AND REGENERATION MARKET: INTEGRATED ECOSYSTEM
Figure 3 TOP-DOWN APPROACH
Figure 4 BOTTOM-UP APPROACH
Figure 5 MACROINDICATOR-BASED APPROACH
Figure 6 NORTH AMERICA NERVE REGENERATION AND REPAIR MARKET SNAPSHOT
Figure 7 NERVE REPAIR AND REGENERATION: COMPARISON WITH PARENT MARKET
Figure 8 NORTH AMERICA: NERVE REPAIR AND REGENERATION MARKET BREAKDOWN
Figure 9 NORTH AMERICA NERVE REPAIR AND REGENERATION MARKET, BY TYPE, 2014–2019 (USD MN)
Figure 10 NORTH AMERICAN NERVE REPAIR AND REGENERATION MARKET, BY PRODUCT: COMPARISON WITH NEUROLOGY DEVICES MARKET, 2013–2019 (USD MN)
Figure 11 NORTH AMERICAN NERVE REPAIR BY BIOMATERIALS MARKET, BY COUNTRY, 2013–2019 (USD MN)
Figure 12 NORTH AMERICA NERVE REPAIR BY NEUROSTIMULATION, BY COUNTRY, 2013–2019 (USD MN)
Figure 13 NORTH AMERICAN NERVE REPAIR AND REGENERATION MARKET: GROWTH ANALYSIS, BY COUNTRY, 2013–2019 (USD MN)
Figure 14 U.S. NERVE REPAIR AND REGENERATION MARKET OVERVIEW, 2014 & 2019 (%)
Figure 15 U.S. NERVE REPAIR AND REGENERATION MARKET, BY TYPE, 2013–2019 (USD MN)
Figure 16 U.S.: NERVE REPAIR AND REGENERATION MARKET, BY TYPE, 2014 VS. 2019 (%)
Figure 17 CANADA: NERVE REPAIR AND REGENERATION MARKET OVERVIEW, 2014 & 2019 (%)
Figure 18 CANADA: NERVE REPAIR AND REGENERATION MARKET, BY PRODUCT, 2013–2019 (USD MN)
Figure 19 CANADA: NERVE REPAIR AND REGENERATION MARKET, BY PRODUCT, 2014 VS
Figure 20 MEXICO NERVE REPAIR AND REGENERATION MARKET OVERVIEW, 2014 & 2019 (%)
Figure 21 MEXICO NERVE REPAIR AND REGENERATION MARKET, BY PRODUCT, 2013–2019 (USD MN)
Figure 22 MEXICO: NERVE REPAIR AND REGENERATION MARKET, BY PRODUCT, 2014 VS 2019
Figure 23 NERVE REPAIR AND REGENERATION MARKET: COMPANY SHARE ANALYSIS, 2013(%)
Figure 24 INTEGRA LIFESCIENCES HOLDINGS CORPORATION: REVENUE MIX, 2013 (%)
Figure 25 CONTRIBUTION OF NEUROSURGERY SEGMENT TOWARDS COMPANY REVENUES, 2008-2013 (USD MN)
Figure 26 STRYKER: GEOGRAPHIC REVENUE MIX, 2013 (%)
Figure 27 ST. JUDE MEDICAL, REVENUE MIX, 2013 (%)
Figure 28 MEDTRONIC, INC.: REVENUE MIX 2013 (%)
